Hans-Jürgen Hoffmann

18PUBLICATIONS
186CO-AUTHORS
AllergyLearning, motivation and emotionCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 30, 2026
Efficacy and Safety of Intralymphatic Immunotherapy With Grass Allergoid and Microcrystalline Tyrosine: A Double-Blind Randomised Placebo-Controlled Trial.

|Feb 27, 2026
Increasing Retention in a Trial by Supporting Basic Psychological Needs for Autonomy, Competence and Relatedness: Developing a Theory-Informed App-Based Complex Intervention.

Anne Poder Petersen, Johannes Martin Schmid, Bjarke Hviid-Vyff

|Nov 10, 2025
Low-Dose Intralymphatic Immunotherapy for Grass Pollen Allergy is Both Safe and Effective.

Bjarke Hviid-Vyff, Søren Helbo Skaarup, Amber Duin

|Jun 09, 2025
Cohort profile: Copenhagen Hospital Biobank-chronic inflammatory disease-inflammatory bowel disease (CHB-CID:IBD) genetic cohort.

Behrooz Darbani, Thorsten Brodersen, Anette Liljensøe

|Aug 07, 2024
Basophil FceRI expression-A management tool in anti-IgE treatment of allergic asthma.

Sune Leisgaard Mørck Rubak, Nadja Lindberg Bonne, Britta Eilertsen Hjerrild

|May 07, 2024
How to hit the allergy target: A critical appraisal of intralymphatic immunotherapy with practical recommendations on ultrasound-guided injections.

Stephan Flory, Bjarke Hviid-Vyff, Lara Šošić

Pageof 3

Frequent Collaborators

5 joint publications

Johannes Schmid

4 joint publications

Oliver Pfaar

3 joint publications

Peter Schmid-Grendelmeier

3 joint publications

Alexandra F Santos